Cargando…
Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study
Epithelioid angiomyolipoma (EAML) is a rare variant of angiomyolipoma (AML). Previous studies have demonstrated that epithelial (E-)cadherin is expressed in two subtypes of AML, EAML and triphasic AML; however, the expression pattern of E-cadherin remains unclear. In the present study, a preliminary...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494718/ https://www.ncbi.nlm.nih.gov/pubmed/28693223 http://dx.doi.org/10.3892/ol.2017.6272 |
_version_ | 1783247712779501568 |
---|---|
author | Bi, Xin-Gang Guo, Lei Wang, Xiao-Liang Wei, Qian Du, Qiang Jiang, Wen-Hao Zheng, Guang-Yuan Zhang, Hong-Tu Ma, Jian-Hui Zheng, Shan |
author_facet | Bi, Xin-Gang Guo, Lei Wang, Xiao-Liang Wei, Qian Du, Qiang Jiang, Wen-Hao Zheng, Guang-Yuan Zhang, Hong-Tu Ma, Jian-Hui Zheng, Shan |
author_sort | Bi, Xin-Gang |
collection | PubMed |
description | Epithelioid angiomyolipoma (EAML) is a rare variant of angiomyolipoma (AML). Previous studies have demonstrated that epithelial (E-)cadherin is expressed in two subtypes of AML, EAML and triphasic AML; however, the expression pattern of E-cadherin remains unclear. In the present study, a preliminary case-control study was conducted to determine the expression pattern of E-cadherin between EAML and triphasic AML, the control, focusing on the subcellular localization and expression category of E-cadherin. No significant difference was identified in the age, sex, history of tuberous sclerosis, smoking and alcohol consumption between the two groups (P>0.05). In EAML, 9 patients were categorized as exhibiting a low risk of malignant behavior and the other two were categorized as exhibiting an intermediate or high risk of malignant behavior. The proportion of cases expressing E-cadherin, human melanoma black-45 (HMB45), melanoma antigen recognized by T cells 1 (Mart1/Melan A), smooth muscle actin and progesterone receptor were 95.5 (21/22), 95.5 (21/22), 86.4 (19/22), 77.3 (17/22) and 86.4% (19/22), respectively. E-cadherin was identified to be localized, using staining techniques, in the cell membrane and/or cytoplasm. The subcellular localization of E-cadherin was significantly different between EAML and triphasic AML; the majority of EAML cases revealed membranous and cytoplasmic staining, whereas triphasic AML cases demonstrated cytoplasmic staining (P=0.0093). The expression of E-cadherin may be positively associated with HMB45 (P=0.0044) and Mart1/Melan A (P=0.0049). The results of the present study identified that the subcellular localization of E-cadherin may be different between EAML and the control group of triphasic AML. Additionally, E-cadherin and melanocytic markers may be co-expressed in distinct subtypes of AML. A follow-up study with a large sample size to validate the results of the present study, followed by a mechanistic study based on cell lines to determine any significance, are warranted. |
format | Online Article Text |
id | pubmed-5494718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-54947182017-07-07 Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study Bi, Xin-Gang Guo, Lei Wang, Xiao-Liang Wei, Qian Du, Qiang Jiang, Wen-Hao Zheng, Guang-Yuan Zhang, Hong-Tu Ma, Jian-Hui Zheng, Shan Oncol Lett Articles Epithelioid angiomyolipoma (EAML) is a rare variant of angiomyolipoma (AML). Previous studies have demonstrated that epithelial (E-)cadherin is expressed in two subtypes of AML, EAML and triphasic AML; however, the expression pattern of E-cadherin remains unclear. In the present study, a preliminary case-control study was conducted to determine the expression pattern of E-cadherin between EAML and triphasic AML, the control, focusing on the subcellular localization and expression category of E-cadherin. No significant difference was identified in the age, sex, history of tuberous sclerosis, smoking and alcohol consumption between the two groups (P>0.05). In EAML, 9 patients were categorized as exhibiting a low risk of malignant behavior and the other two were categorized as exhibiting an intermediate or high risk of malignant behavior. The proportion of cases expressing E-cadherin, human melanoma black-45 (HMB45), melanoma antigen recognized by T cells 1 (Mart1/Melan A), smooth muscle actin and progesterone receptor were 95.5 (21/22), 95.5 (21/22), 86.4 (19/22), 77.3 (17/22) and 86.4% (19/22), respectively. E-cadherin was identified to be localized, using staining techniques, in the cell membrane and/or cytoplasm. The subcellular localization of E-cadherin was significantly different between EAML and triphasic AML; the majority of EAML cases revealed membranous and cytoplasmic staining, whereas triphasic AML cases demonstrated cytoplasmic staining (P=0.0093). The expression of E-cadherin may be positively associated with HMB45 (P=0.0044) and Mart1/Melan A (P=0.0049). The results of the present study identified that the subcellular localization of E-cadherin may be different between EAML and the control group of triphasic AML. Additionally, E-cadherin and melanocytic markers may be co-expressed in distinct subtypes of AML. A follow-up study with a large sample size to validate the results of the present study, followed by a mechanistic study based on cell lines to determine any significance, are warranted. D.A. Spandidos 2017-07 2017-05-29 /pmc/articles/PMC5494718/ /pubmed/28693223 http://dx.doi.org/10.3892/ol.2017.6272 Text en Copyright: © Bi et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Bi, Xin-Gang Guo, Lei Wang, Xiao-Liang Wei, Qian Du, Qiang Jiang, Wen-Hao Zheng, Guang-Yuan Zhang, Hong-Tu Ma, Jian-Hui Zheng, Shan Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
title | Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
title_full | Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
title_fullStr | Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
title_full_unstemmed | Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
title_short | Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
title_sort | distinct subcellular localization of e-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: a preliminary case-control study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494718/ https://www.ncbi.nlm.nih.gov/pubmed/28693223 http://dx.doi.org/10.3892/ol.2017.6272 |
work_keys_str_mv | AT bixingang distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT guolei distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT wangxiaoliang distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT weiqian distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT duqiang distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT jiangwenhao distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT zhengguangyuan distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT zhanghongtu distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT majianhui distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy AT zhengshan distinctsubcellularlocalizationofecadherinbetweenepithelioidangiomyolipomaandtriphasicangiomyolipomaapreliminarycasecontrolstudy |